Mean sojourn time, overdiagnosis, and reduction in advanced stage prostate cancer due to screening with PSA: implications of sojourn time on screening

This study aimed to assess the mean sojourn time (MST) of prostate cancer, to estimate the probability of overdiagnosis, and to predict the potential reduction in advanced stage disease due to screening with PSA. The MST of prostate cancer was derived from detection rates at PSA prevalence testing i...

Descripción completa

Detalles Bibliográficos
Autores principales: Pashayan, N, Duffy, S W, Pharoah, P, Greenberg, D, Donovan, J, Martin, R M, Hamdy, F, Neal, D E
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2009
Materias:
Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2670005/
https://www.ncbi.nlm.nih.gov/pubmed/19293796
http://dx.doi.org/10.1038/sj.bjc.6604973

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2670005/
https://www.ncbi.nlm.nih.gov/pubmed/19293796
http://dx.doi.org/10.1038/sj.bjc.6604973

Ejemplares similares